Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Here’s the most recent PR on Kevetirn.

http://www.ipharminc.com/press-release/2017/12/27/innovation-pharmaceuticals-obtains-direct-evidence-of-molecular-pathways-modulation-in-tumors-from-first-patients-in-kevetrin-ph2a-ovarian-cancer-trial

Those who understand science also understand the significance of confirming the p53 pathway. Those who don’t understand will keep using people work for a paycheck, pre-revenue biotech dilutes and drug development takes time as scare tactics.